Compared to pure SCLC, combined SCLC is thought to derive more benefit from surgery, less benefit from chemotherapy and radiotherapy, and more benefit from targeted therapy, especially anti-EGFR tyrosine kinase inhibitors [5]. Here, EGFR is linked to small cell lung carcinoma.